CD36 and neoplasm: Our investigations encompass the interplay between activin A and CD36 expression in normal primary FBs; growth suppression as a result of exposure of the tumor cells to the CM of CD36+ FBs in multiple cell lines and a partial mechanism via identifying relevant transcription factors, and identifying active factors and their effective concentrations that induce growth suppression.